Australia, April 9 -- MAAT PHARMA, owns the trademark (2616222) for 'XERVYTEG' and '3 CRESCENTS ATOP LTR X' till Oct. 30, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, nam...